AHFS September 2024 Update

This update contains 2 new monographs and 29 revised monographs.

New monographs: Elafibrinor; Imetelstat Sodium.

Revised monographs: Abatacept; Amifampridine Phosphate; Asciminib Hydrochloride; azaCITIdine; Bosentan; Dalfampridine; Delandistrogene Moxeparvovec-rokl; Deutetrabenazine; Dimethyl Fumarate; Diroximel Fumarate; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate; Elranatamab-bcmm; Enzalutamide; Fosamprenavir Calcium; L-Glutamine; Lisocabtagene Maraleucel; Momelotinib Dihydrochloride; Morphine Sulfate; Nabilone; Nelfinavir Mesylate; Nevirapine; Niraparib Tosylate; Omacetaxine Mepesuccinate; Omidenepag Isopropyl; Palbociclib; Relugolix; Ritlecitinib Tosylate; Ruxolitinib Phosphate (Topical); Tuberculin Purified Protein Derivative (Interdermal).